Long-term classification stability and treatment patterns of inflammatory bowel disease unclassified: a longitudinal observational study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Longitudinal Analysis of Treatment Approaches and Classification Consistency in Inflammatory Bowel Disease Unclassified

  • By

  • Mario Andrea Latorre

  • Michael Rennie

  • Konstantina Rosiou

  • Marco Vincenzo Lenti

  • Christian Philipp Selinger

  • June 11, 2026

Share

  • 1

    The study analyzed 153 patients with Inflammatory Bowel Disease Unclassified (IBD-U) over a long-term follow-up period.

  • 2

    Patients with IBD-U had a mean age of 46.6 years and a mean disease duration of 13.1 years.

  • 3

    IBD-U patients were less likely to receive mesalazine compared to ulcerative colitis but more likely than Crohn's disease patients.

  • 4

    Biologics were used more frequently in IBD-U patients than in ulcerative colitis patients but less than in Crohn's disease patients.

  • 5

    At the end of follow-up, 88.2% of patients remained classified as IBD-U, indicating stability in diagnosis over time.

Original Source(s)

Long-term classification stability and treatment patterns of inflammatory bowel disease unclassified: a longitudinal observational study

  • by Mario Andrea Latorre, Michael Rennie, Konstantina Rosiou, Marco Vincenzo Lenti, Christian Philipp Selinger

  • June 11, 2026

Related Content

Estrogen receptors and the NRF2 pathway: bridging hormonal regulation and stress response in the gut

Casein hydrolysate promotes intestinal repair in adult mice with Salmonella enteritis through a lactate-GPR81-Wnt3A axis in intestinal stem cell niche

Real-world patterns of inflammatory bowel disease treatment across adult and pediatric populations: a nationwide cohort study in South Korea